Grb7-based molecular therapeutics in cancer

Expert Reviews in Molecular Medicine

Volumn 5, Issue 14, 2003, Pages

  Pero, Stephanie C ^a   Daly, Roger J ^b   Krag, David N ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

cancer; ErbB2; Grb7; peptide; receptor tyrosine kinase; SH2 domain; signal transduction inhibitor; targeted therapeutics

Indexed keywords

GROWTH FACTOR RECEPTOR BOUND PROTEIN 7;

CHEMISTRY; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; NEOPLASM; PHYSIOLOGY; REVIEW; SRC HOMOLOGY DOMAIN;

DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GRB7 ADAPTOR PROTEIN; HUMANS; NEOPLASMS; SRC HOMOLOGY DOMAINS;

EID: 84867533585     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399403006227     Document Type: Review

References (82)

1. Mills, G.B., Lu, Y. and Kohn, E.C. (2001) Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo. Proc Natl Acad Sci USA 98, 10031-10033, PubMed: 21417775
2. Baselga, J. et al. (1996) Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol 14, 737-744, PubMed: 96186197
3. Hidalgo, M. et al. (2001) Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies. J Clin Oncol 19, 3267-3279, PubMed: 21326212 (Pubitemid 32591445)
4. Eckhardt, S.G. et al. (1999) Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors. J Clin Oncol 17, 1095-1104, PubMed: 20029895 (Pubitemid 29162931)
5. Capdeville, R. et al. (2002) Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1, 493-502, PubMed: 22116377
6. Vu, C.B. (2000) Recent advances in the design and synthesis of SH2 inhibitors of Src, Grb2 and ZAP-70. Curr Med Chem 7, 1081-1100, PubMed: 20381426
7. Burke, T.R., Jr. et al. (2001) Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors. Biopolymers 60, 32-44, PubMed: 21269935
8. Botfield, M.C. and Green, J. (1995)SH2 and SH3 domains: choreographer's of multiple signalling pathways. J Annu Rep Med Chem 227-237
9. Pero, S.C. et al. (2002) Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7. J Biol Chem 277, 11918-11926, PubMed: 21922846 (Pubitemid 34952750)
10. Sadowski, I., Stone, J.C. and Pawson, T. (1986) A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol 6, 4396-4408, PubMed: 87089798 (Pubitemid 17217381)
11. Pawson, T. (1988) Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction. Oncogene 3, 491-495, PubMed: 90272217 (Pubitemid 19003651)
12. Pawson, T., Gish, G.D. and Nash, P. (2001) SH2 domains, interaction modules and cellular wiring. Trends Cell Biol 11, 504-511, PubMed: 21576840 (Pubitemid 33079144)
13. Pawson, T. (1994) SH2 and SH3 domains in signal transduction. Adv Cancer Res 64, 87-110, PubMed: 95185362 (Pubitemid 24351294)
14. Margolis, B. (1994) The GRB family of SH2 domain proteins. Prog Biophys Mol Biol 62, 223-244, PubMed: 95199592 (Pubitemid 124002416)
15. Poy, F. et al. (1999) Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol Cell 4, 555-561, PubMed: 20017053 (Pubitemid 29531135)
16. Songyang, Z. et al. (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778, PubMed: 93201599 (Pubitemid 23093884)
17. Obermeier, A. et al. (1993) Tyrosine 785 is a major determinant of Trk-substrate interaction. Embo J 12, 933-941, PubMed: 93209240 (Pubitemid 23095842)
18. Batzer, A.G. et al. (1994) Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol Cell Biol 14, 5192-5201, PubMed: 94309639
19. Margolis, B. et al. (1992) High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. Proc Natl Acad Sci USA 89, 8894-8898, PubMed: 93028373
20. Skolnik, E.Y. et al. (1991) Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65, 83-90, PubMed: 91191565 (Pubitemid 121001216)
21. Pawson, T. and Scott, J.D. (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080, PubMed: 98071002 (Pubitemid 28028310)
22. Frantz, J.D. et al. (1997) Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. J Biol Chem 272, 2659-2667, PubMed: 97160567 (Pubitemid 27053306)
23. Manser, J., Roonprapunt, C. and Margolis, B. (1997) C. elegans cell migration gene mig-10 shares similarities with a family of SH2 domain proteins and acts cell nonautonomously in excretory canal development. Dev Biol 184, 150-164, PubMed: 97287863 (Pubitemid 27225705)
24. Ooi, J. et al. (1995) The cloning of Grb10 reveals a new family of SH2 domain proteins. Oncogene 10, 1621-1630, PubMed: 95249278
25. Stein, D. et al. (1994) The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. Embo J 13, 1331-1340, PubMed: 94185639 (Pubitemid 24090214)
26. Manser, J. and Wood, W.B. (1990) Mutations affecting embryonic cell migrations in Caenorhabditis elegans. Dev Genet 11, 49-64, PubMed: 90298583 (Pubitemid 20208941)
27. Shen, T.L., Han, D.C. and Guan, J.L. (2002) Association of Grb7 with phosphoinositides and its role in the regulation of cell migration. J Biol Chem 277, 29069-29077, PubMed: 22151071
28. Wojcik, J. et al. (1999) Sequence analysis identifies a ras-associating (RA)-like domain in the N-termini of band 4.1/JEF domains and in the Grb7/10/14 adapter family. Biochem Biophys Res Commun 259, 113-120, PubMed: 99268807 (Pubitemid 29264003)
29. He, W. et al. (1998) Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains. J Biol Chem 273, 6860-6867, PubMed: 98175951 (Pubitemid 28160349)
30. Vayssiere, B. et al. (2000) Interaction of the Grb7 adapter protein with Rnd1, a new member of the Rho family. FEBS Lett 467, 91-96, PubMed: 20130024 (Pubitemid 30069549)
31. Janes, P.W. et al. (1997) Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7. J Biol Chem 272, 8490-8497, PubMed: 97236805 (Pubitemid 27147812)
32. Jones, N. et al. (1999) Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274, 30896-30905, PubMed: 99452988
33. Han, D.C., Shen, T.L. and Guan, J.L. (2000) Role of Grb7 targeting to focal contacts and its phosphorylation by focal adhesion kinase in regulation of cell migration. J Biol Chem 275, 28911-28917, PubMed: 20435855
34. Han, D.C. and Guan, J.L. (1999) Association of focal adhesion kinase with Grb7 and its role in cell migration. J Biol Chem 274, 24425-24430, PubMed: 99377086
35. Frisch, S.M. et al. (1996) Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134, 793-799, PubMed: 96326682 (Pubitemid 26269148)
36. Ilic, D. et al. (1995) Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544, PubMed: 96013747
37. Zhao, J.H., Reiske, H. and Guan, J.L. (1998) Regulation of the cell cycle by focal adhesion kinase. J Cell Biol 143, 1997-2008, PubMed: 99085075 (Pubitemid 29022619)
38. Guan, J.L. (1997) Focal adhesion kinase in integrin signaling. Matrix Biol 16, 195-200, PubMed: 98065571
39. Richardson, A. et al. (1997) Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol Cell Biol 17, 6906-6914, PubMed: 98038759 (Pubitemid 27505920)
40. Xing, Z. et al. (1994) Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Mol Biol Cell 5, 413-421, PubMed: 94331781 (Pubitemid 24178320)
41. Cobb, B.S. et al. (1994) Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol Cell Biol 14, 147-155, PubMed: 94088511
42. Schaller, M.D. et al. (1994) Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 14, 1680-1688, PubMed: 94158840
43. Chan, P.Y. et al. (1994) A transmembrane-anchored chimeric focal adhesion kinase is constitutively activated and phosphorylated at tyrosine residues identical to pp125FAK. J Biol Chem 269, 20567-20574, PubMed: 94327635
44. Chen, H.C. and Guan, J.L. (1994) Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 91, 10148-10152, PubMed: 95024002
45. Chen, H.C. et al. (1996) Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J Biol Chem 271, 26329-26334, PubMed: 96421638
46. Tanaka, S. et al. (1998) A novel variant of human Grb7 is associated with invasive esophageal carcinoma. J Clin Invest 102, 821-827, PubMed: 98376491 (Pubitemid 28399615)
47. Tanaka, S. et al. (2000) Grb7 signal transduction protein mediates metastatic progression of esophageal carcinoma. J Cell Physiol 183, 411-415, PubMed: 20259890 (Pubitemid 30243872)
48. Kishi, T. et al. (1997) Molecular cloning of human GRB-7 co-amplified with CAB1 and c-ERBB-2 in primary gastric cancer. Biochem Biophys Res Commun 232, 5-9, PubMed: 97236270 (Pubitemid 27211909)
49. Tsuda, H. and Hirohashi, S. (1998) Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c-erbB-2 expression patterns in both the non-invasive and invasive portions. Pathol Int 48, 518-525, PubMed: 98364744 (Pubitemid 28341088)
50. Slamon, D.J. et al. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182, PubMed: 87094192 (Pubitemid 17231334)
51. Seshadri, R. et al. (1993) Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. J Clin Oncol 11, 1936-1942, PubMed: 94015213 (Pubitemid 23304619)
52. Gullick, W.J. (1990) The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer. Int J Cancer Suppl 5, 55-61, PubMed: 91078909
53. Oligino, L. et al. (1997) Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain. J Biol Chem 272, 29046-29052, PubMed: 98030583
54. Hart, C.P. et al. (1999) Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries. Cell Signal 11, 453-464, PubMed: 99325905 (Pubitemid 29234131)
55. Gay, B. et al. (1999) Selective GRB2 SH2 inhibitors as anti-Ras therapy. Int J Cancer 83, 235-241, PubMed: 99400680 (Pubitemid 29449103)
56. Fendly, B.M. et al. (1990) Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res 50, 1550-1558, PubMed: 90150117 (Pubitemid 20090470)
57. Hudziak, R.M. et al. (1989) p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol 9, 1165-1172, PubMed: 89261720 (Pubitemid 19071685)
58. Tanaka, S. et al. (1997) Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Cancer Res 57, 28-31, PubMed: 97141776 (Pubitemid 27020323)
59. Fiddes, R.J. et al. (1998) Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3. J Biol Chem 273, 7717-7724, PubMed: 98184886 (Pubitemid 28152802)
60. Garcia-Echeverria, C. (2001) Antagonists of the Src homology 2 (SH2) domains of Grb2, Src, Lck and ZAP-70. Curr Med Chem 8, 1589-1604, PubMed: 21446456 (Pubitemid 33076804)
61. Atabey, N. et al. (2001) Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. J Biol Chem 276, 14308-14314, PubMed: 21216737
62. Garbay, C. et al. (2000) Inhibitors of Ras signal transduction as antitumor agents. Biochem Pharmacol 60, 1165-1169, PubMed: 20464907
63. Furet, P. et al. (1997) Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domain. J Med Chem 40, 3551-3556, PubMed: 98020393 (Pubitemid 27465087)
64. Gay, B. et al. (1999) Effect of potent and selective inhibitors of the Grb2 SH2 domain on cell motility. J Biol Chem 274, 23311-23315, PubMed: 99367461
65. Cussac, D. et al. (1999) A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity. Faseb J 13, 31-38, PubMed: 99091526 (Pubitemid 29038272)
66. Kato, D. et al. (1998) Features of replicative senescence induced by direct addition of antennapedia-p16INK4A fusion protein to human diploid fibroblasts. FEBS Lett 427, 203-208, PubMed: 98268328 (Pubitemid 28225058)
67. Lin, Y.Z. et al. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270, 14255-14258, PubMed: 95301500
68. Rojas, M., Yao, S. and Lin, Y.Z. (1996) Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem 271, 27456-27461, PubMed: 97066925 (Pubitemid 26367305)
69. Park, J.W. et al. (1997) Immunoliposomes for cancer treatment. Adv Pharmacol 40, 399-435, PubMed: 97360969
70. Park, J.W. et al. (2001) Tumor targeting using anti-her2 immunoliposomes. J Control Release 74, 95-113, PubMed: 21382302 (Pubitemid 32727613)
71. Slamon, D. and Pegram, M. (2001) Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials. Semin Oncol 28, 13-19, PubMed: 21198152
72. Milenic, D.E. et al. (1991) Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 51, 6363-6371, PubMed: 92034771
73. Fujimori, K. et al. (1989) Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors. Cancer Res 49, 5656-5663, PubMed: 90002920 (Pubitemid 19256448)
74. Tahtis, K. et al. (2001) Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model. Clin Cancer Res 7, 1061-1072, PubMed: 21206452 (Pubitemid 32708746)
75. Yokota, T. et al. (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 52, 3402-3408, PubMed: 92282621
76. Thommes, K. et al. (1999) Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor. Biochem J 341, 211-216, PubMed: 99306874 (Pubitemid 29359067)
77. Keegan, K. and Cooper, J.A. (1996) Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, SHPTP2, with another SH2-containing protein, Grb7. Oncogene 12, 1537-1544, PubMed: 96204009
78. Yokote, K. et al. (1996) Grb7 is a downstream signaling component of platelet-derived growth factor alpha-and beta-receptors. J Biol Chem 271, 30942-30949, PubMed: 97094847
79. Pandey, A. et al. (1996) Direct association between the Ret receptor tyrosine kinase and the Src homology 2-containing adapter protein Grb7. J Biol Chem 271, 10607-10610, PubMed: 96209985 (Pubitemid 26149895)
80. Kasus-Jacobi, A. et al. (2000) Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2. Oncogene 19, 2052-2059, PubMed: 20260602 (Pubitemid 30229418)
81. Han, D.C. et al. (2002) EphB1 associates with Grb7 and regulates cell migration. J Biol Chem 277, 45655-45661, PubMed: 22323212 (Pubitemid 36159177)
82. Lee, H. et al. (2000) Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol 14, 1750-1775, PubMed: 20525068